PharmaHub · Veterinary & Animal Health · Asia Pacific

Asia Pacific Companion Animal Health Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends 2026-2030

The Asia Pacific companion animal health market encompasses veterinary pharmaceuticals, vaccines, diagnostics, and medical devices for pets such as dogs, cats, and other companion animals. Valued at approximately $4.99 billion in 2025, the market is projected to grow at a compound annual rate of 10.73%, driven by rising pet ownership, increasing disposable incomes, and growing awareness of animal health across the region. It represents one of the fastest-growing segments within the broader Asia Pacific animal health industry. Key market forces include the trend of pet humanization, expanding veterinary infrastructure, and the introduction of advanced treatment options.

Market size · 2025
$5 billion
CAGR · 2025–2030
10.73%
Forecast · 2030
$8.3 billion
Basis
Claight Analysis
Market size (USD)
Base year 2025
Official data · Claight AnalysisForecast
Market size and forecast are Claight Analysis, informed by public research.
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2025 base: $5bn2030 est: $8.3bn
Read the full Asia Pacific Companion Animal Health Market Report report →

Market Overview

The Asia Pacific companion animal health market covers products and services used to prevent, diagnose, and treat diseases in companion animals, including dogs, cats, birds, and exotic pets. Products span pharmaceuticals, vaccines, parasiticides, diagnostics, and surgical equipment, while services include veterinary care, animal health clinics, and diagnostic laboratories. The market operates within a broader regional animal health ecosystem that includes livestock and aquaculture segments, with companion animals representing the fastest-growing sub-sector.

  • Market estimated at approximately $4.51 billion in 2024, growing to roughly $4.99 billion in 2025
  • Projected to reach approximately $11.26 billion by 2033 at a 10.73% CAGR
  • Companion animal health is the fastest-growing segment within the broader Asia Pacific animal health market, estimated at $15.5 billion in 2025

Growth Drivers

Pet humanization is the primary catalyst for market expansion, as more households across Asia Pacific treat companion animals as family members, increasing spending on preventive care and advanced treatments. Rising disposable incomes in emerging economies such as India, China, and Southeast Asian nations have enabled greater investment in pet health products and veterinary services. Expanding urbanization, declining household sizes, and growing awareness of zoonotic diseases have further accelerated demand for companion animal healthcare solutions.

  • Pet ownership rates are rising sharply in emerging markets, with more households seeking premium veterinary care and pharmaceutical products
  • Increased spending on pet insurance and willingness to pay for advanced diagnostics and specialty care treatments
  • Government and NGO initiatives promoting responsible pet ownership, animal welfare standards, and disease surveillance programs
Want a deeper cut on Asia Pacific Companion Animal Health Market Report? We build bespoke studies on request.
Connect to an analyst →

Segmentation and Regional Analysis

The market is typically segmented by product type, including pharmaceuticals (the largest segment), vaccines, diagnostics, and medical feed additives. Geographically, developed markets such as Japan, Australia, and South Korea lead in per-capita companion animal health spending, while China and India represent the highest growth opportunities due to expanding middle-class populations and increasing pet adoption rates. Southeast Asian countries including Thailand, Indonesia, and Vietnam are emerging markets with accelerating demand driven by urbanization and rising pet ownership.

  • Japan, Australia, and South Korea hold the largest market shares in absolute terms, supported by established veterinary infrastructure and high pet ownership rates
  • China and India are the fastest-expanding markets, fueled by growing middle-class populations, urbanization, and shifting cultural attitudes toward pet ownership
  • Southeast Asian nations collectively represent a significant emerging opportunity, with increasing veterinary clinic penetration and pet product retail availability

Trends and Outlook

What are the recent trends and outlook?

The market is expected to maintain double-digit growth through the forecast period, supported by continued expansion of the pet population, growing veterinary infrastructure, and rising demand for premium and specialty pet care products. Digitalization of veterinary services, including telemedicine and online pharmacy platforms, is reshaping how companion animal health products reach consumers. Innovations in biologics, monoclonal antibody therapies, and precision diagnostics are expected to create new product opportunities, while increasing regulatory harmonization across Asia Pacific markets may facilitate faster product approvals and market access for international and domestic manufacturers.

  • Telemedicine and digital health platforms for pets are gaining traction, particularly in urban centers, enabling remote consultations and online prescription fulfillment
  • Biologics, including monoclonal antibody treatments for conditions such as osteoarthritis and dermatological disorders in companion animals, represent a high-growth product category
  • Regulatory harmonization and increased government oversight of animal health products are improving market transparency and product quality standards across the region
Talk to a Claight analyst
Do you want to research Asia Pacific Companion Animal Health Market Report?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.